Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Agnes Jager

23PUBLICATIONS
200CO-AUTHORS
Cancer geneticsMedical biotechnology diagnostics (incl. biosensors)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Nanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

Sort by Publication Date:
|Nov 18, 2025
Correction: Barriers and facilitators for medical oncologists in the further implementation of mainstream genetic testing in breast cancer care in the Netherlands.

Chiem L de Jong, Gina Schijven, Ellen G Engelhardt

|Oct 14, 2025
Barriers and facilitators for medical oncologists in the further implementation of mainstream genetic testing in breast cancer care in the Netherlands.

Chiem L de Jong, Gina Schijven, Ellen G Engelhardt

|Sep 04, 2025
Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer: circulating tumor DNA analysis of a randomized phase 3 trial.

Elisabeth M Jongbloed, Noor Wortelboer, Vanja de Weerd

|Jul 22, 2025
Author Correction: Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer.

Gabe S Sonke, Annemiek van Ommen-Nijhof, Noor Wortelboer

|Feb 21, 2025
Environmental Impact Assessment of Intravenous Versus Subcutaneous Monoclonal Antibodies: A Carbon Footprint Analysis.

Michiel Zietse, Thirza Kooijman, Ruben Malmberg

|Feb 17, 2025
Development and validation of a functional ex vivo paclitaxel and eribulin sensitivity assay for breast cancer, the REMIT assay.

Zofia M Komar, Nicole S Verkaik, Ahmed Dahmani

Pageof 4

Frequent Collaborators

4 joint publications

Gabe S Sonke

4 joint publications

Hedwig M Blommestein

3 joint publications

Noor Wortelboer

3 joint publications

Petra Nederlof

3 joint publications

Margreet G E M Ausems

3 joint publications

Dik C van Gent

3 joint publications

Ron H J Mathijssen

3 joint publications

Sanne M Buijs

2 joint publications

Ellen G Engelhardt

2 joint publications

Frederik Marmé

Frequent Collaborators

4 joint publications

Gabe S Sonke

4 joint publications

Hedwig M Blommestein

3 joint publications

Noor Wortelboer

3 joint publications

Petra Nederlof

Top Related Videos

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
07:59

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on : Sep 08, 2023

1.6K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on : Jul 25, 2020

7.4K
See more related videos

Top Related Videos

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
07:59

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on : Sep 08, 2023

1.6K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on : Jul 25, 2020

7.4K
See more related videos